Greenrise Global Brands Inc. (XCX.CN)
| Previous Close | 0.0300 |
| Open | 0.0200 |
| Bid | 0.0150 x N/A |
| Ask | 0.0300 x N/A |
| Day's Range | 0.0200 - 0.0200 |
| 52 Week Range | 0.0200 - 0.2900 |
| Volume | |
| Avg. Volume | 5,090 |
| Market Cap | 944,720 |
| Beta (5Y Monthly) | -0.48 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1250 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 03, 2012 |
| 1y Target Est | N/A |
- CNW Group
Greenrise Announces Record Sales for Q2 and Comments on Positive Developments regarding the Legislation of Adult-Use Cannabis in Germany
Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise" and "the Company") is pleased to provide preliminary, unaudited second quarter financial results for the three months ending June 30, 2022 ("Q2") and commentary on recent developments in the adult use of cannabis legislation in Germany.
- CNW Group
Greenrise Provides Update on CannaCare's Sales Growth and First Quarter Results
Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise"), which operates in the German CBD wellbeing and medical cannabis market announces its results for the three months ending March 31st, 2022 (Q1, 2022) and provides an update about the acquisition of CannaCare Health GmbH ("CannaCare").
- CNW Group
Greenrise Announces Appointment of Frank Otto to the Board of Directors and Closing of the Acquisition of Control of CannaCare Health GmbH
Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise''), which serves the medical and CBD cannabis market in Germany and CannaCare Health GmbH ("CannaCare"), owner of CANOBO, one of Germany's leading CBD brands announces the appointment of Mr. Frank Otto to the board of directors of Greenrise and the closing of the acquisition of 51% of CannaCare Health GmbH ("CannaCare") previously announced on April 5th, 2022. Greenrise has the exclusive option to purchase
